Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

QUALITROL IMMUNOLOGY CONTROL, LEVEL 1, 2 AND 3

K-Number: K992770 · 1999-11-12

ApplicantSeracare Technology
Decision Date1999-11-12
Product CodeJJY
Advisory CommitteeCH
DecisionSubstantially Equivalent

Device Summary

QUALITROL IMMUNOLOGY CONTROL, LEVEL 1, 2 AND 3 is the device name listed in this FDA 510(k) record. The listed applicant is Seracare Technology. It received FDA 510(k) clearance on 1999-11-12 under 510(k) number K992770. The device is classified under product code JJY. It was reviewed by the CH advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the QUALITROL IMMUNOLOGY CONTROL, LEVEL 1, 2 AND 3?

QUALITROL IMMUNOLOGY CONTROL, LEVEL 1, 2 AND 3 is a medical device that received FDA 510(k) clearance on 1999-11-12. The listed applicant is Seracare Technology. The 510(k) number is K992770.

When did QUALITROL IMMUNOLOGY CONTROL, LEVEL 1, 2 AND 3 receive FDA 510(k) clearance?

QUALITROL IMMUNOLOGY CONTROL, LEVEL 1, 2 AND 3 received FDA 510(k) clearance on 1999-11-12, under 510(k) number K992770.

Who is the listed applicant for QUALITROL IMMUNOLOGY CONTROL, LEVEL 1, 2 AND 3?

The FDA 510(k) record lists Seracare Technology as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for QUALITROL IMMUNOLOGY CONTROL, LEVEL 1, 2 AND 3?

The FDA product code for QUALITROL IMMUNOLOGY CONTROL, LEVEL 1, 2 AND 3 is JJY.

Related Clinical Trials

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

NCT07608549FLASH Pilot Phase 1 Safety StudyNOT_YET_RECRUITINGNCT06562205PAP Systems External Clinical Studies (ECS)NOT_YET_RECRUITINGNCT06443177The Effect of Sympathetic Modulation on Cerebral Vasospasm Secondary to Aneurysmal Subarachnoid HemorrhageSUSPENDEDNCT07095751Artificial Intelligence-assisted Uro-Cam Catheter Assessment System for Diagnosing Bladder CancerNOT_YET_RECRUITING

Other records listing Seracare Technology as applicant

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

K992939QUALITROL IMMUNOASSAY PLUS CONTROL, LEVELS 1,2 AND 3K993631QUALITROL TUMOR MARKER CONTROL, LEVELS 1 AND 2K993715QUALITROL CARDIAC MARKER CONTROL, LEVELS, 1,2 AND 3K992395URINE DRUG SCREENING CONTROL

Related Devices (Code: JJY)

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

K162530Multichem IA PlusTechno-Path ManufacturingK163629Audit MicroControls Linearity FD Tumor Markers IIAalto Scientific, Ltd.K163015Liquichek Tumor Marker Control-Level 1; Liquichek Tumor Marker Control-Level 2; Liquichek Tumor Marker Control-Level 3; Liquichek Tumor Marker Control- Trilevel MiniPakBio-Rad LaboratoriesK153712VK-3 Verification Kit, VK-4 Verification Kit, VK-R5 Verification Kit, VK-R7 Verification Kit, VK-Crea Verification KitRadiometer America, Inc.K132227LIQUICHEK IMMUNOASSAY PREMIUM CONTROL-TRILEVEL, LIQUICHEK IMMUNOASSAY PREMIUM CONTROL-LEVEL I, LIQUICHEK IMMUNOASSAYBio-Rad LaboratoriesK132156RANDOX CSF CONTROLS LEVELS 2 AND 3Randox Laboratories, Ltd.

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.

↑